Movano Inc. (NASDAQ:MOVE) Short Interest Update

Movano Inc. (NASDAQ:MOVE) was the recipient of a large decline in short interest during the month of February. As of February 27th, there was short interest totaling 21,839 shares, a decline of 36.4% from the February 12th total of 34,360 shares. Based on an average daily volume of 46,049 shares, the short-interest ratio is currently 0.5 days. Approximately 2.1% of the company’s shares are short sold. Approximately 2.1% of the company’s shares are short sold. Based on an average daily volume of 46,049 shares, the short-interest ratio is currently 0.5 days.

Insiders Place Their Bets

In other news, CEO John Mastrototaro sold 33,069 shares of the company’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total transaction of $687,835.20. Following the transaction, the chief executive officer owned 56,114 shares of the company’s stock, valued at $1,167,171.20. This represents a 37.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CTO Michael Aaron Leabman sold 6,845 shares of Movano stock in a transaction dated Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the sale, the chief technology officer owned 22,639 shares of the company’s stock, valued at approximately $150,775.74. The trade was a 23.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 94,383 shares of company stock valued at $1,524,933. 10.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new position in shares of Movano Inc. (NASDAQ:MOVE) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano at the end of the most recent reporting period. 16.64% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short‑term technical strength: the share price is trading above both its 50‑day ($11.82) and 200‑day ($9.30) simple moving averages, a signal that traders often treat as a buy trigger for momentum trades.
• Positive Sentiment: Low float / micro‑cap dynamics can amplify small buy orders into visible price gains — helpful for quick upside when there’s even modest demand.
• Neutral Sentiment: Healthcare/biotech headlines remain active (which can lift investor interest in small medical names), but recent items are about large-cap drugmakers and lifecycle plays rather than Movano specifically. Pfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
• Neutral Sentiment: Broader market sentiment pieces (e.g., on payments/tech or macro headlines) can shift risk appetite and small‑cap flows that move names like MOVE, but they’re indirect drivers. Why PayPal’s Rally Faded—And What Could Restart It
• Neutral Sentiment: Geopolitical and commodity stories (oil/tankers, crypto volatility) are keeping overall market volatility elevated — that can produce intermittent demand for and selling of speculative small caps. Trump’s Move to Seize Oil Tankers Costs the U.S. Tens of Millions of Dollars
• Negative Sentiment: Very light trading today (≈18.8k shares vs. ~1.24M average) means the move may be ephemeral — a handful of trades can swing the price on a micro‑cap.
• Negative Sentiment: Company fundamentals remain a risk: tiny market cap, negative earnings, and a large 52‑week high/low spread imply high execution and liquidity risk for investors holding through volatility.

Movano Stock Performance

NASDAQ:MOVE traded up $0.21 during mid-day trading on Friday, hitting $13.24. The company had a trading volume of 18,805 shares, compared to its average volume of 45,507. Movano has a fifty-two week low of $4.67 and a fifty-two week high of $34.87. The business’s fifty day moving average is $11.91 and its two-hundred day moving average is $9.35. The firm has a market cap of $15.12 million, a P/E ratio of -1.22 and a beta of 0.86.

Analysts Set New Price Targets

Several equities research analysts have recently commented on MOVE shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. Wall Street Zen raised shares of Movano from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.